Buprenorphine waiver training is available for physicians interested in seeking their waiver to prescribe buprenorphine in the treatment of opioid use disorders. To obtain the waiver to prescribe, providers are required to take eight (8) hours of training.
Following training, physicians who have successfully completed the course may apply to the SAMHSA to obtain the waiver. PCSS-MAT urges all physicians who complete the course to submit a Notice of Intent Form to SAMHSA to obtain their waiver to prescribe. The waiver must be completed online and a link to the online form will be provided to participants following the training.
PCSS-MAT has a comprehensive library of materials available at no cost created to give physicians confidence in treating these complex patients. PCSS-MAT has a no-cost clinical coaching/mentoring program (http://pcssmat.org/mentoring/) to provide one-on-one expert help to primary care providers.
This webinar addresses the opioid public health crisis. This comprehensive course was developed by renowned experts from Collaborative for REMS Education (CO*RE) and incorporates all six units outlined in FDA blueprint for safe opioid prescribing. ASAM's course also provides an additional unit addressing the common and complex overlap between opioid use and opioid addiction. The American Society of Addiction Medicine designates this live activity for a maximum of 3 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.